Literature DB >> 1578934

Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.

P Stryckmans, T De Witte, J P Marie, G Fillet, M Peetermans, J Bury, P Muus, J M Andrien, M Hayat, B Jaksic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1578934

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma.

Authors:  R Willemze; J M Zijlmans; G J den Ottolander; J C Kluin-Nelemans; J H Falkenburg; C W Starrenburg; J F van der Burgh; W E Fibbe
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

2.  High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL)--a single-institution study.

Authors:  R Scherrer; P Bettelheim; K Geissler; U Jäger; P Knöbl; P A Kyrle; K Laczika; G Mitterbauer; E Neumann; B Schneider
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

3.  Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.

Authors:  Sook-Ryun Park; Jee Hyun Kim; Do Yeun Kim; Sehoon Lee; Sang-Yoon Lee; In Sil Choi; Sung-Soo Yoon; Seonyang Park; Byuoung-Gook Kim; Noe Kyoung Kim
Journal:  Korean J Intern Med       Date:  2003-03       Impact factor: 2.884
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.